Gene therapies are the most expensive drugs in the world. And that is because producing a viral vector for "in vivo" gene therapy is arguably the most complicated process ever attempted at scale in biopharmaceuticals. In a prior video, I talked about the Chinese hamster's revolutionary impact on scaling antibody manufacturing. Today, let’s double-click on that (hate this phrase). In this video, we look at the history and complex manufacturing issues of viral vector gene therapy.

Get all episodes of Asianometry, Sharp Tech, Sharp China, Stratechery Updates and Interviews, Greatest of All Talk, and Dithering as part of Stratechery Plus for $15/month or $150/year.

Listen to Stratechery.

Listen to Dithering.

Listen to Sharp China.

Listen to Sharp Tech.

Listen to Greatest Of All Talk.